On the positive side, continued growth in sales of key drugs like Darzalex, along with newer products such as Erleada and ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...

Johnson & Johnson shares tumbled Tuesday to lead S&P 500 decliners after the health care giant failed to reach a settlement ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of Johnson & Johnson ( JNJ 3.04%) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m. ET. The drop ...

However, despite a 5% stock increase in the last quarter, JNJ's performance remained largely aligned with market movements, which experienced a volatile phase due to broad economic uncertainties ...

Johnson & Johnson (JNJ) is expected to deliver a year ... estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top ...

Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a ...